K. Shannak

发表

Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications.

S. Kish, K. Shannak, O. Hornykiewicz, 1988, The New England journal of medicine.

Normal serotonin but elevated 5-hydroxyindoleacetic acid concentration in cerebellar cortex of patients with dominantly-inherited olivopontocerebellar atrophy

S. Kish, K. Shannak, M. Ball, 1992, Neuroscience Letters.

Influence of Chronic Cocaine on Monoamine Neurotransmitters in Human Brain and Animal Model: Preliminary Observations

J. Nobrega, S. Kish, K. Shannak, 1992, Annals of the New York Academy of Sciences.

Striatal ganglioside levels in the rat following kainic acid lesions: Comparison with Huntington's disease

K. Shannak, O. Hornykiewicz, G. Sperk, 2004, Experimental Brain Research.

Dementia, parkinsonism, and motor neuron disease: Neurochemical and neuropathological correlates

S. Kish, K. Shannak, O. Hornykiewicz, 1988, Annals of neurology.

Aging Produces a Specific Pattern of Striatal Dopamine Loss: Implications for the Etiology of Idiopathic Parkinson's Disease

S. Kish, K. Shannak, O. Hornykiewicz, 1992, Journal of neurochemistry.

Striatal dopamine nerve terminal markers in human, chronic methamphetamine users

A. Levey, J. Haycock, S. Kish, 1996, Nature Medicine.

Brain monoamine changes in chronic paranoid schizophrenia and their possible relation to increased dopamine receptor sensitivity.

K. Shannak, O. Hornykiewicz, I. Farley, 1980, Advances in biochemical psychopharmacology.

Brain neurotransmitter changes in human narcolepsy

S. Kish, K. Shannak, O. Hornykiewicz, 1992, Neurology.

Reversible drug-induced parkinsonism: clinicopathologic study of two cases

K. Shannak, O. Hornykiewicz, A. Rajput, 1983 .

Reversible drug-induced parkinsonism. Clinicopathologic study of two cases.

K. Shannak, O. Hornykiewicz, B. Rozdilsky, 1982, Archives of neurology.

Brain neurotransmitters in dystonia musculorum deformans.

S. Kish, K. Shannak, O. Hornykiewicz, 1986, The New England journal of medicine.

Striatal dopamine, dopamine transporter, and vesicular monoamine transporter in chronic cocaine users

A. Levey, S. Kish, K. Shannak, 1996, Annals of neurology.

Heterogeneous subregional binding patterns of 3H-WIN 35,428 and 3H-GBR 12,935 are differentially regulated by chronic cocaine self- administration

S J Kish, K. Shannak, M. Carroll, 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

Biochemical evidence of dysfunction of brain neurotransmitters in the Lesch-Nyhan syndrome.

K. Shannak, O. Hornykiewicz, K. Lloyd, 1981, The New England journal of medicine.

The pallido-subthalamic projection in rat: Anatomical and biochemical studies

D. Kooy, K. Shannak, O. Hornykiewicz, 1981, Brain Research.

Elevated serotonin and reduced dopamine in subregionally divided Huntington's disease striatum

S. Kish, K. Shannak, O. Hornykiewicz, 1987, Annals of neurology.

Biochemical evidence for brain neurotransmitter changes in idiopathic torsion dystonia (dystonia musculorum deformans).

S. Kish, K. Shannak, O. Hornykiewicz, 1988, Advances in neurology.

Dopa‐responsive dystonia: Pathological and biochemical observations in a case

W. Gibb, S. Kish, K. Shannak, 1994, Annals of neurology.

Amygdala dopamine levels are markedly elevated after self- but not passive-administration of cocaine

Stephen J. Kish, J. Nobrega, S. Kish, 1994, Brain Research.

Progressive supranuclear palsy: Relationship between extrapyramidal disturbances, dementia, and brain neurotransmitter markers

S. Kish, K. Shannak, O. Hornykiewicz, 1985, Annals of neurology.

Elevated γ‐aminobutyric acid level in striatal but not extrastriatal brain regions in Parkinson's disease: Correlation with striatal dopamine loss

S. Kish, K. Shannak, O. Hornykiewicz, 1986, Annals of neurology.

Noradrenaline, dopamine and serotonin levels and metabolism in the human hypothalamus: observations in Parkinson's disease and normal subjects

S. Kish, K. Shannak, O. Hornykiewicz, 1994, Brain Research.

Differential changes in neurochemical markers of striatal dopamine nerve terminals in idiopathic Parkinson's disease

A. Levey, S. Kish, K. Shannak, 1996, Neurology.

Striatal monoamine neurotransmitters and metabolites in dominantly inherited olivopontocerebellar atrophy

S. Kish, K. Shannak, M. Ball, 1992, Neurology.

Cerebellar norepinephrine in patients with Parkinson's disease and control subjects.

S. Kish, K. Shannak, O. Hornykiewicz, 1984, Archives of neurology.

Brain monoamines in progressive supranuclear palsy--comparison with idiopathic Parkinson's disease.

K. Shannak, O. Hornykiewicz, 1994, Journal of neural transmission. Supplementum.

Striatal dihydroxyphenylalanine decarboxylase and tyrosine hydroxylase protein in idiopathic Parkinson's disease and dominantly inherited olivopontocerebellar atrophy

J. Haycock, S. Kish, K. Shannak, 1995, Movement disorders : official journal of the Movement Disorder Society.

GABA-dopamine relationship in Parkinson's disease striatum.

S. Kish, K. Shannak, O. Hornykiewicz, 1987, Advances in neurology.

Reduced brain 5-HT and elevated NE turnover and metabolites in bipolar affective disorder

S. Kish, K. Shannak, J. Warsh, 1994, Biological Psychiatry.

Reduction of Noradrenaline in Cerebellum of Patients with Olivopontocerebellar Atrophy

S. Kish, K. Shannak, O. Hornykiewicz, 1984, Journal of neurochemistry.

Brain monoamines in the rhesus monkey during long-term neuroleptic administration.

K. Shannak, O. Hornykiewicz, 1980, Advances in biochemical psychopharmacology.